Preferred Name |
dezocine |
|
Synonyms |
Wy-16,225 |
|
ID |
http://purl.bioontology.org/ontology/MESH/C010827 |
|
altLabel |
Wy-16,225 dezocine hydrobromide, (5alpha,11alpha,13S*)-isomer 13-amino-5,6,7,8,9,10,11,12-octahydro-5-methyl-5,11-methanobenzocyclodecenol 5,11-Methanobenzocyclodecen-3-ol, 5,6,7,8,9,10,11,12-octahydro-13-amino-5-methyl- (-5alpha, 11alpha,13s)-13-amino-5,6,7,8,9,10,11,12-octahydro-5-methyl-5,11-methanobenzocyclodecen-3-ol dezocine hydrobromide, (5alpha,11alpha,13*)-isomer 5,11-methanobenzocyclodecen-3-ol, 13-amino-5,6,7,8,9,10,11,12-octahydro-5-methyl-, (5alpha,11alpha,13s*) dezocine, (5alpha,11alpha,13S*)-isomer dezocine hydrobromide, (5R-(5alpha,11alpha,13S*))-isomer dezocine hydrobromide, (5S-(5alpha,11alpha,13*))-isomer |
|
cui |
C0057626 C0952190 C0952189 C0952188 C0148897 C0969989 C0087252 |
|
HM |
D013764 D019086 |
|
Inverse of RB |
42013-66-1 57236-36-9 83461-52-3 VHX8K5SV4X 58383-80-5 42264-28-8 0 |
|
isa | ||
Mapped to | ||
MDA |
19760101 |
|
MeSH Frequency |
136 |
|
MMR |
20170724 |
|
notation |
C010827 |
|
PA |
D000701 |
|
PI |
*CYCLOPARAFFINS (1983-2007) *BRIDGED COMPOUNDS (76-82) |
|
prefLabel |
dezocine |
|
RR |
42013-66-1 (HBr(5alpha,11alpha,13S*)-isomer) 57236-36-9 (HBr(5R-(5alpha,11alpha,13S*))-isomer) 58383-80-5 (HBr(5S-(5alpha,11alpha,13*))-isomer) 52437-65-7 (parent) 42264-28-8 (HBr(5alpha,11alpha,13*)-(+-)-isomer) 83461-52-3 ((5alpha,11alpha,13S*)-isomer) 53648-55-8 (dezocine) |
|
SC |
1 |
|
Scope Statement |
potent analgesic; RN given refers to ((5R-(5alpha,11alpha,13S*)))-isomer (dezocin); structure |
|
SRC |
Anesth Analg 57(5):563;1978 Curr Med Res Opin 1980;6(7):472 J Pharmacol Exptl Therap 194(3):488;1975 |
|
TERMUI |
T086653 T000929051 T341258 T086652 T341263 T341262 T341261 T341259 T086651 T000929052 |
|
TH |
USAN (1976) NLM (1976) FDA SRS (2017) INN (19XX) NLM (2017) |
|
tui |
T109 T121 |